Genetically engineered mesenchymal stem cells as a proposed therapeutic for huntington's disease

Molecular Neurobiology

Volumn 45, Issue 1, 2012, Pages 87-98

  Olson, Scott D ^a   Pollock, Kari ^a   Kambal, Amal ^a   Cary, Whitney ^a   Mitchell, Gaela Marie ^a   Tempkin, Jeremy ^a   Stewart, Heather ^a   McGee, Jeannine ^a   Bauer, Gerhard ^a   Kim, Hyun Sook ^a,c   Tempkin, Teresa ^b   Wheelock, Vicki ^b   Annett, Geralyn ^a   Dunbar, Gary ^d   Nolta, Jan A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHA University   (South Korea)

^d CENTRAL MICHIGAN UNIVERSITY   (United States)

Author keywords

BDNF; Clinical trials; Human mesenchymal stem cells; Huntington's disease; Hypoxia; Neurite outgrowth; Neurodegenerative diseases; Tissue repair

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; FREE RADICAL; NERVE GROWTH FACTOR; NEURITE PROMOTING FACTOR;

APOPTOSIS; ARTICLE; CLINICAL TRIAL (TOPIC); DEGENERATIVE DISEASE; GENE OVEREXPRESSION; GENETIC ENGINEERING; HUMAN; HUNTINGTON CHOREA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE FIBER GROWTH; NERVE GROWTH; NONHUMAN; PARACRINE SIGNALING; SYNAPTIC TRANSMISSION;

EID: 84856742161     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-011-8219-8     Document Type: Article

References (111)

1. N Joyce G Annett L Wirthlin S Olson G Bauer JA Nolta 2010 Mesenchymal stem cells for the treatment of neurodegenerative disease Regenerative med 5 933 946 10.2217/rme.10.72
2. T Meyerrose S Olson S Pontow S Kalomoiris Y Jung G Annett G Bauer JA Nolta 2010 Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors Adv drug deliv rev 62 1167 1174 20920540 10.1016/j.addr.2010. 09.013 1:CAS:528:DC%2BC3cXhsVGitb%2FJ
3. K Le Blanc 2006 Mesenchymal stromal cells: tissue repair and immune modulation Cytotherapy 8 559 561 17148032 10.1080/14653240601045399 (Pubitemid 44869856)
4. JM Hare JH Traverse TD Henry N Dib RK Strumpf SP Schulman G Gerstenblith AN DeMaria AE Denktas RS Gammon JB Hermiller Jr MA Reisman GL Schaer W Sherman 2009 A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 2277 2286 19958962 10.1016/j.jacc.2009.06.055 1:CAS:528:DC%2BC3cXmsl2guw%3D%3D
5. RE Newman D Yoo MA LeRoux A Danilkovitch-Miagkova 2009 Treatment of inflammatory diseases with mesenchymal stem cells Inflamm allergy drug targets 8 110 123 19530993 10.2174/187152809788462635 1:CAS:528:DC%2BD1MXotFKgtrk%3D
6. MA Laflamme CE Murry 2005 Regenerating the heart Nat Biotechnol 23 845 856 16003373 10.1038/nbt1117 1:CAS:528:DC%2BD2MXlvFegs7k%3D (Pubitemid 43093128)
7. J Chen Y Li M Katakowski X Chen L Wang D Lu M Lu SC Gautam M Chopp 2003 Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat J Neurosci Res 73 778 786 12949903 10.1002/jnr.10691 1:CAS:528:DC%2BD3sXnt1Wqu7g%3D (Pubitemid 37071731)
8. Y Li J Chen CL Zhang L Wang D Lu M Katakowski Q Gao LH Shen J Zhang M Lu M Chopp 2005 Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells Glia 49 407 417 15540231 10.1002/glia.20126 (Pubitemid 40222918)
9. JM Murphy DJ Fink EB Hunziker FP Barry 2003 Stem cell therapy in a caprine model of osteoarthritis Arthritis Rheum 48 3464 3474 14673997 10.1002/art.11365 (Pubitemid 37531912)
10. Rosova I, Dao M, Capoccia B, Link D, Nolta JA (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173-2182
11. T Kinnaird E Stabile MS Burnett CW Lee S Barr S Fuchs SE Epstein 2004 Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ Res 94 678 685 14739163 10.1161/01.RES.0000118601. 37875.AC 1:CAS:528:DC%2BD2cXitVGksr4%3D (Pubitemid 38387752)
12. M Gnecchi H He N Noiseux OD Liang L Zhang F Morello H Mu LG Melo RE Pratt JS Ingwall VJ Dzau 2006 Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J 20 661 669 16581974 10.1096/fj.05-5211com 1:CAS:528:DC%2BD28XjtlensLc%3D (Pubitemid 44933310)
13. BJ Capoccia DL Robson KD Levac DJ Maxwell SA Hohm MJ Neelamkavil GI Bell A Xenocostas DC Link D Piwnica-Worms JA Nolta DA Hess 2009 Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity Blood 113 5340 5351 19324906 10.1182/blood-2008-04-154567 1:CAS:528:DC%2BD1MXmslaksro%3D
14. I Rosova M Dao B Capoccia D Link JA Nolta 2008 Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells Stem Cells 26 2173 2182 18511601 10.1634/stemcells.2007- 1104 1:CAS:528:DC%2BD1cXhtVKmt7vJ
15. GD Wu JA Nolta YS Jin ML Barr H Yu VA Starnes DV Cramer 2003 Migration of mesenchymal stem cells to heart allografts during chronic rejection Transplantation 75 679 685 12640309 10.1097/01.TP.0000048488.35010.95 (Pubitemid 36337368)
16. T Meyerrose D De Ugarte A Hofling PE Herrbrich TD Cordonnier LD Shultz JC Eagon L Wirthlin MS Sands MA Hedrick JA Nolta 2007 In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models Stem Cells 25 220 227 16960135 10.1634/stemcells.2006-0243 1:CAS:528: DC%2BD2sXhvVGjtbg%3D (Pubitemid 46052993)
17. TE Meyerrose M Roberts KK Ohlemiller CA Vogler L Wirthlin JA Nolta MS Sands 2008 Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease Stem Cells 26 1713 1722 18436861 10.1634/stemcells.2008-0008 1:CAS:528:DC%2BD1cXpvV2murc%3D
18. G Bauer MA Dao SS Case T Meyerrose L Wirthlin P Zhou X Wang P Herrbrich J Arevalo S Csik DC Skelton J Walker K Pepper DB Kohn JA Nolta 2008 In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors Mol Ther 16 1308 1315 18461052 10.1038/mt.2008.93 1:CAS:528:DC%2BD1cXns1ehsrs%3D (Pubitemid 351866063)
19. MA Dao KA Pepper JA Nolta 1997 Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model Stem Cells 15 443 454 9402657 10.1002/stem.150443 1:CAS:528:DyaK2sXnvFagsrw%3D (Pubitemid 27513719)
20. Nolta J (2006) Genetic Engineering of Mesenchymal Stem Cells: Kluwer.
21. L Danielyan R Schafer A von Ameln-Mayerhofer M Buadze J Geisler T Klopfer U Burkhardt B Proksch S Verleysdonk M Ayturan GH Buniatian CH Gleiter WH Frey 2nd 2009 Intranasal delivery of cells to the brain Eur j cell biol 88 315 324 19324456 10.1016/j.ejcb.2009.02.001 1:CAS:528:DC%2BD1MXlslOltrc%3D
22. J Rossignol C Boyer R Thinard S Remy AS Dugast D Dubayle ND Dey F Boeffard J Delecrin D Heymann B Vanhove I Anegon P Naveilhan GL Dunbar L Lescaudron 2009 Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation J Cell Mol Med 13 2547 2558 20141619
23. L Crigler RC Robey A Asawachaicharn D Gaupp DG Phinney 2006 Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis Exp Neurol 198 54 64 16336965 10.1016/j.expneurol.2005.10.029 1:CAS:528:DC%2BD28Xhs1Snsrk%3D (Pubitemid 43243744)
24. JR Munoz BR Stoutenger AP Robinson JL Spees DJ Prockop 2005 Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice Proc Natl Acad Sci U S A 102 18171 18176 16330757 10.1073/pnas.0508945102 1:CAS:528:DC%2BD2MXhtlersrvN (Pubitemid 41798520)
25. I Kassis N Grigoriadis B Gowda-Kurkalli R Mizrachi-Kol T Ben-Hur S Slavin O Abramsky D Karussis 2008 Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis Arch Neurol 65 753 761 18541795 10.1001/archneur.65.6.753 (Pubitemid 351831453)
26. SA Busch JA Hamilton KP Horn FX Cuascut R Cutrone N Lehman RJ Deans AE Ting RW Mays J Silver 2011 Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury J Neurosci 31 944 953 21248119 10.1523/JNEUROSCI.3566-10.2011 1:CAS:528:DC%2BC3MXhsVemtrg%3D
27. A Vercelli OM Mereuta D Garbossa G Muraca K Mareschi D Rustichelli I Ferrero L Mazzini E Madon F Fagioli 2008 Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis Neurobiol Dis 31 395 405 18586098 10.1016/j.nbd.2008.05.016 1:CAS:528:DC%2BD1cXhtVSis77J
28. E Morita Y Watanabe M Ishimoto T Nakano M Kitayama K Yasui Y Fukada K Doi A Karunaratne WG Murrell R Sutharsan A Mackay-Sim Y Hata K Nakashima 2008 A novel cell transplantation protocol and its application to an ALS mouse model Exp Neurol 213 431 438 18691571 10.1016/j.expneurol.2008.07.011 1:CAS:528:DC%2BD1cXhtFamsrfN
29. C Josse R Schoemans NA Niessen M Delgaudine AC Hellin C Herens P Delvenne V Bours 2010 Systematic chromosomal aberrations found in murine bone marrow-derived mesenchymal stem cells Stem cells dev 19 1167 1173 20109032 10.1089/scd.2009.0264 1:CAS:528:DC%2BC3cXhtVejs77F
30. GV Rosland A Svendsen A Torsvik E Sobala E McCormack H Immervoll J Mysliwietz JC Tonn R Goldbrunner PE Lonning R Bjerkvig C Schichor 2009 Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation Cancer Res 69 5331 5339 19509230 10.1158/0008-5472.CAN-08-4630 1:CAS:528:DC%2BD1MXnvFWqu70%3D
31. A Torsvik GV Rosland A Svendsen A Molven H Immervoll E McCormack PE Lonning M Primon E Sobala JC Tonn R Goldbrunner C Schichor J Mysliwietz TT Lah H Motaln S Knappskog R Bjerkvig 2010 Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track-letter Cancer Res 70 6393 6396 20631079 10.1158/0008-5472.CAN-10- 1305 1:CAS:528:DC%2BC3cXpsVCnu78%3D
32. YH Choi A Kurtz C Stamm 2011 Mesenchymal stem cells for cardiac cell therapy Hum Gene Ther 22 3 17 21062128 10.1089/hum.2010.211 1:CAS:528: DC%2BC3MXhs1KltbY%3D
33. GW Dryden 2009 Overview of stem cell therapy for Crohn's disease Expert Opin Biol Ther 9 841 847 19527107 10.1517/14712590902956615 1:CAS:528: DC%2BD1MXnt1Shs74%3D
34. P Kebriaei S Robinson 2011 Treatment of graft-versus-host-disease with mesenchymal stromal cells Cytotherapy 13 262 268 21231805 10.3109/14653249.2010. 549688
35. MA Matthay BT Thompson EJ Read DH McKenna Jr KD Liu CS Calfee JW Lee 2010 Therapeutic potential of mesenchymal stem cells for severe acute lung injury Chest 138 965 972 20923800 10.1378/chest.10-0518
36. NK Satija VK Singh YK Verma P Gupta S Sharma F Afrin M Sharma P Sharma RP Tripathi GU Gurudutta 2009 Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine J Cell Mol Med 13 4385 4402 19602034 10.1111/j.1582-4934.2009.00857.x 1:CAS:528:DC%2BC3cXkvFGjs7k%3D
37. D Spitkovsky J Hescheler 2008 Adult mesenchymal stromal stem cells for therapeutic applications Minim Invasive Ther Allied Technol 17 79 90 18465443 10.1080/13645700801969758 1:STN:280:DC%2BD1czgtlGhug%3D%3D (Pubitemid 351942702)
38. KT Wright WE Masri A Osman J Chowdhury WE Johnson 2011 Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications Stem Cells 29 169 178 21732476 10.1002/stem.570 1:CAS:528:DC%2BC3MXks1altrk%3D
39. S Kidd E Spaeth JL Dembinski M Dietrich K Watson A Klopp VL Battula M Weil M Andreeff FC Marini 2009 Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging Stem Cells 27 2614 2623 19650040 10.1002/stem.187 1:CAS:528:DC%2BD1MXhsFenurzK
40. S Kidd E Spaeth A Klopp M Andreeff B Hall FC Marini 2008 The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe Cytotherapy 10 657 667 18985472 10.1080/14653240802486517 1:STN:280: DC%2BD1cjhvFSrtg%3D%3D
41. Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS (2009) Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study. Mov Disord 24:1763-1772
42. JS Paulsen VA Magnotta AE Mikos HL Paulson E Penziner NC Andreasen PC Nopoulos 2006 Brain structure in preclinical Huntington's disease Biol Psychiatry 59 57 63 16112655 10.1016/j.biopsych.2005.06.003 1:CAS:528: DC%2BD28Xks1en (Pubitemid 43005236)
43. HJ Kim E McMillan F Han CN Svendsen 2009 Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1 Stem Cells 27 390 398 19008346 10.1634/stemcells.2007-1047 1:CAS:528:DC%2BD1MXjslSjtr0%3D
44. J Sharp HS Keirstead 2009 Stem cell-based cell replacement strategies for the central nervous system Neurosci Lett 456 107 111 19429144 10.1016/j.neulet.2008.04.106 1:CAS:528:DC%2BD1MXltVCqtr0%3D
45. SA Hardy DJ Maltman SA Przyborski 2008 Mesenchymal stem cells as mediators of neural differentiation Curr stem cell res ther 3 43 52 18220922 10.2174/157488808783489471 1:CAS:528:DC%2BD1cXisFSlsrs%3D (Pubitemid 352024866)
46. K Montzka N Lassonczyk B Tschoke S Neuss T Fuhrmann R Franzen R Smeets GA Brook M Woltje 2009 Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression BMC Neurosci 10 16 19257891 10.1186/1471-2202-10-16
47. PB Gahan M Stroun 2010 The virtosome-a novel cytosolic informative entity and intercellular messenger Cell Biochem Funct 28 529 538 20941743 10.1002/cbf.1690 1:CAS:528:DC%2BC3cXhsVeisbfP
48. HH Gerdes RN Carvalho 2008 Intercellular transfer mediated by tunneling nanotubes Curr Opin Cell Biol 20 470 475 18456488 10.1016/j.ceb.2008.03.005 1:CAS:528:DC%2BD1cXoslOntbw%3D
49. M Simons G Raposo 2009 Exosomes-vesicular carriers for intercellular communication Curr Opin Cell Biol 21 575 581 19442504 10.1016/j.ceb.2009.03.007 1:CAS:528:DC%2BD1MXps1Cltbc%3D
50. S Bruno C Grange MC Deregibus RA Calogero S Saviozzi F Collino L Morando A Busca M Falda B Bussolati C Tetta G Camussi 2009 Mesenchymal stem cell-derived microvesicles protect against acute tubular injury J Am Soc Nephrol 20 1053 1067 19389847 10.1681/ASN.2008070798 1:CAS:528:DC%2BD1MXlvFKqtrY%3D
51. PJ Quesenberry JM Aliotta 2008 The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles Stem Cell Rev 4 137 147 18665337 10.1007/s12015-008-9036-y 1:CAS:528:DC%2BD1cXht1Sqsb%2FO
52. AM Skinner SL O'Neill P Kurre 2009 Cellular microvesicle pathways can be targeted to transfer genetic information between non-immune cells PLoS One 4 e6219 19593443 10.1371/journal.pone.0006219
53. Taylor DD, Gercel-Taylor C (2011) Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Seminars Immunopathol 33:441-454
54. J Ratajczak K Miekus M Kucia J Zhang R Reca P Dvorak MZ Ratajczak 2006 Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery Leukemia 20 847 856 16453000 10.1038/sj.leu.2404132 1:CAS:528:DC%2BD28XjslOhsbs%3D
55. Olson SD, Kambal A, Pollock K, Mitchell GM, Stewart H, Kalomoiris S, Cary W, Nacey C, Pepper K, Nolta JA (2011) Examination of Mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin. Molecular Neurology (in press)
56. JL Spees SD Olson MJ Whitney DJ Prockop 2006 Mitochondrial transfer between cells can rescue aerobic respiration Proc Natl Acad Sci U S A 103 1283 1288 16432190 10.1073/pnas.0510511103 1:CAS:528:DC%2BD28Xhs1Gguro%3D (Pubitemid 43191157)
57. Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N (2011) Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res
58. I Aizman CC Tate M McGrogan CC Case 2009 Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth J Neurosci Res 87 3198 3206 19530164 10.1002/jnr.22146 1:CAS:528:DC%2BD1MXhtFagur%2FN
59. AP Croft SA Przyborski 2009 Mesenchymal stem cells expressing neural antigens instruct a neurogenic cell fate on neural stem cells Exp Neurol 216 329 341 19159625 10.1016/j.expneurol.2008.12.010 1:CAS:528:DC%2BD1MXjsVOjt70%3D
60. GJ Delcroix PC Schiller JP Benoit CN Montero-Menei 2010 Adult cell therapy for brain neuronal damages and the role of tissue engineering Biomaterials 31 2105 2120 20005569 10.1016/j.biomaterials.2009.11.084 1:CAS:528:DC%2BC3cXpsV2isw%3D%3D
61. C Zuccato A Ciammola D Rigamonti BR Leavitt D Goffredo L Conti ME MacDonald RM Friedlander V Silani MR Hayden T Timmusk S Sipione E Cattaneo 2001 Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 293 493 498 11408619 10.1126/science.1059581 1:CAS:528: DC%2BD3MXlsFGjtr0%3D (Pubitemid 32679077)
62. C Zuccato M Valenza E Cattaneo 2010 Molecular mechanisms and potential therapeutical targets in Huntington's disease Physiol Rev 90 905 981 20664076 10.1152/physrev.00041.2009 1:CAS:528:DC%2BC3cXhtVyku7rN
63. SD Croll C Suri DL Compton MV Simmons GD Yancopoulos RM Lindsay SJ Wiegand JS Rudge HE Scharfman 1999 Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex Neuroscience 93 1491 1506 10501474 10.1016/S0306-4522(99)00296-1 1:CAS:528:DyaK1MXls1Wisrw%3D (Pubitemid 29397578)
64. RL Boudreau JL McBride I Martins S Shen Y Xing BJ Carter BL Davidson 2009 Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice Mol Ther 17 1053 1063 19240687 10.1038/mt.2009.17 1:CAS:528:DC%2BD1MXit1agtb4%3D
65. SQ Harper PD Staber X He SL Eliason IH Martins Q Mao L Yang RM Kotin HL Paulson BL Davidson 2005 RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model Proc Natl Acad Sci U S A 102 5820 5825 15811941 10.1073/pnas.0501507102 1:CAS:528:DC%2BD2MXjslaktbo%3D (Pubitemid 40559643)
66. M DiFiglia M Sena-Esteves K Chase E Sapp E Pfister M Sass J Yoder P Reeves RK Pandey KG Rajeev M Manoharan DW Sah PD Zamore N Aronin 2007 Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits Proc Natl Acad Sci U S A 104 17204 17209 17940007 10.1073/pnas.0708285104 1:CAS:528:DC%2BD2sXht1Kit7rK (Pubitemid 350211015)
67. YL Wang W Liu E Wada M Murata K Wada I Kanazawa 2005 Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA Neurosci Res 53 241 249 16095740 10.1016/j.neures.2005.06.021 1:CAS:528:DC%2BD2MXhtFektbzN (Pubitemid 41463777)
68. MS Lombardi L Jaspers C Spronkmans C Gellera F Taroni E Di Maria SD Donato WF Kaemmerer 2009 A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference Exp Neurol 217 312 319 19289118 10.1016/j.expneurol.2009.03.004 1:CAS:528:DC%2BD1MXlvF2ktrg%3D
69. EL Pfister L Kennington J Straubhaar S Wagh W Liu M DiFiglia B Landwehrmeyer JP Vonsattel PD Zamore N Aronin 2009 Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients Curr Biol 19 774 778 19361997 10.1016/j.cub.2009.03.030 1:CAS:528: DC%2BD1MXlslWmt7w%3D
70. Y Zhang J Engelman RM Friedlander 2009 Allele-specific silencing of mutant Huntington's disease gene J Neurochem 108 82 90 19094060 10.1111/j.1471-4159.2008.05734.x 1:CAS:528:DC%2BD1MXns1Wrtw%3D%3D
71. L Lescaudron D Unni GL Dunbar 2003 Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes Int J Neurosci 113 945 956 12881187 10.1080/ 00207450390207759 (Pubitemid 36975650)
72. K Bantubungi D Blum L Cuvelier S Wislet-Gendebien B Rogister E Brouillet SN Schiffmann 2008 Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease Mol Cell Neurosci 37 454 470 18083596 10.1016/j.mcn.2007.11.001 1:CAS:528:DC%2BD1cXislWltrs%3D
73. EM Amin BA Reza BR Morteza MM Maryam M Ali N Zeinab 2008 Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration Neurol Res 30 1086 1090 18768110 10.1179/174313208X327955
74. C Watts IR McNamara SB Dunnett 2000 Volume and differentiation of striatal grafts in rats: relationship to the number of cells implanted Cell transplant 9 65 72 10784068 1:STN:280:DC%2BD3c3ksVKmtg%3D%3D (Pubitemid 30438907)
75. ND Dey MC Bombard BP Roland S Davidson M Lu J Rossignol MI Sandstrom RL Skeel L Lescaudron GL Dunbar 2010 Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease Behav brain res 214 193 200 20493905 10.1016/j.bbr.2010.05.023 1:CAS:528:DC%2BC3cXpsFKrsbY%3D
76. Edalatmanesh MA, Matin MM, Neshati Z, Bahrami AR, Kheirabadi M (2010) Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum. Neurol Res 32:166-172
77. Im W, Lee ST, Park JE, Oh HJ, Shim J, Lim J, Chu K, Kim M (2010) Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice. PLoS Curr 2
78. Y Jiang H Lv S Huang H Tan Y Zhang H Li 2011 Bone marrow mesenchymal stem cells can improve the motor function of a Huntington's disease rat model Neurol Res 33 331 337 21513650 1:CAS:528:DC%2BC3MXotFymt74%3D
79. ST Lee K Chu KH Jung WS Im JE Park HC Lim CH Won SH Shin SK Lee M Kim JK Roh 2009 Slowed progression in models of Huntington disease by adipose stem cell transplantation Ann Neurol 66 671 681 19938161 10.1002/ana.21788 1:CAS:528:DC%2BC3cXjslCgtA%3D%3D
80. YT Lin Y Chern CK Shen HL Wen YC Chang H Li TH Cheng HM Hsieh-Li 2011 Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models PLoS One 6 e22924 21850243 10.1371/journal.pone.0022924 1:CAS:528:DC%2BC3MXhtFajt7nO
81. J Rossignol C Boyer X Leveque KD Fink R Thinard F Blanchard GL Dunbar L Lescaudron 2011 Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes Behav brain res 217 369 378 21070819 10.1016/j.bbr.2010.11.006 1:CAS:528:DC%2BC3cXhs1Wkt7bP
82. O Sadan N Shemesh R Barzilay M Bahat-Stromza E Melamed Y Cohen D Offen 2008 Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging Stem Cells 26 2542 2551 18635865 10.1634/stemcells.2008-0240 1:CAS:528:DC%2BD1cXhtlyku7rL
83. GJ Delcroix M Jacquart L Lemaire L Sindji F Franconi JJ Le Jeune CN Montero-Menei 2009 Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain Brain res 1255 18 31 19103182 10.1016/j.brainres.2008.12.013 1:CAS:528:DC%2BD1MXhtlequ74%3D
84. O Sadan N Shemesh Y Cohen E Melamed D Offen 2009 Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases Isr Med Assoc J 11 201 204 19603590
85. AC Bachoud-Levi V Gaura P Brugieres JP Lefaucheur MF Boisse P Maison S Baudic MJ Ribeiro C Bourdet P Remy P Cesaro P Hantraye M Peschanski 2006 Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study Lancet Neurol 5 303 309 16545746 10.1016/S1474-4422(06)70381-7
86. V Gaura AC Bachoud-Levi MJ Ribeiro JP Nguyen V Frouin S Baudic P Brugieres JF Mangin MF Boisse S Palfi P Cesaro Y Samson P Hantraye M Peschanski P Remy 2004 Striatal neural grafting improves cortical metabolism in Huntington's disease patients Brain 127 65 72 14607797 10.1093/brain/awh003 (Pubitemid 38055346)
87. CA Altar N Cai T Bliven M Juhasz JM Conner AL Acheson RM Lindsay SJ Wiegand 1997 Anterograde transport of brain-derived neurotrophic factor and its role in the brain Nature 389 856 860 9349818 10.1038/39885 1:CAS:528: DyaK2sXmvFSku7c%3D (Pubitemid 27462980)
88. ZC Baquet JA Gorski KR Jones 2004 Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor J Neurosci 24 4250 4258 15115821 10.1523/JNEUROSCI.3920-03.2004 1:CAS:528:DC%2BD2cXjvFemsLc%3D (Pubitemid 38620801)
89. C Zuccato E Cattaneo 2009 Brain-derived neurotrophic factor in neurodegenerative diseases Nat rev 5 311 322 1:CAS:528:DC%2BD1MXntVSqtL8%3D
90. Arregui L, Benitez JA, Razgado LF, Vergara P, Segovia J (2011) Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington's disease delays the onset of the motor phenotype. Cell Mol Neurobiol 31:1229-1243
91. J Alberch E Perez-Navarro JM Canals 2004 Neurotrophic factors in Huntington's disease Prog brain res 146 195 229 14699966 1:CAS:528: DC%2BD2cXkslWntQ%3D%3D (Pubitemid 37541385)
92. C Zuccato E Cattaneo 2007 Role of brain-derived neurotrophic factor in Huntington's disease Prog Neurobiol 81 294 330 17379385 10.1016/j.pneurobio. 2007.01.003 1:CAS:528:DC%2BD2sXjvFGqtL0%3D (Pubitemid 46528643)
93. Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL (2010) Genetically-engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res 214:193-200
94. Meyerrose T, Rosova I, Dao M, Herrbrich P, Bauer G, Nolta J (2006) Establishment and transduction of primary human stromal/mesenchymal stem cell monolayers, Vol. Chapter 2. Kluwer Academic, Dordrecht
95. JA Nolta MA Dao S Wells EM Smogorzewska DB Kohn 1996 Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice Proc Natl Acad Sci U S A 93 2414 2419 8637888 10.1073/pnas.93.6.2414 1:CAS:528:DyaK28XhvVSktL8%3D (Pubitemid 26104364)
96. JA Nolta DB Kohn 1990 Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells Hum Gene Ther 1 257 268 2081193 10.1089/hum.1990.1.3-257 1:STN:280:DyaK3M7ot1yqug%3D%3D (Pubitemid 120034731)
97. E Tsark M Dao X Wang K Weinberg J Nolta 2001 IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice J Immunol 166 170 181 11123290 1:CAS:528:DC%2BD3MXis1aktw%3D%3D (Pubitemid 32038430)
98. X Wang S Ge G McNamara QL Hao GM Crooks JA Nolta 2003 Albumin expressing hepatocyte-like cells develop in the livers of immune-deficient mice transmitted with highly purified human hematopoietic stem cells Blood 101 10 4201 4208 12560238 10.1182/blood-2002-05-1338 1:CAS:528:DC%2BD3sXktVGms78%3D (Pubitemid 36857905)
99. JA Nolta MB Hanley DB Kohn 1994 Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors Blood 83 3041 3051 7514050 1:CAS:528:DyaK2cXlslSntL0%3D (Pubitemid 24142740)
100. L Mazzini F Fagioli R Boccaletti K Mareschi G Oliveri C Olivieri I Pastore R Marasso E Madon 2003 Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans Amyotroph Lateral Scler Other Motor Neuron Disord 4 158 161 13129802 10.1080/14660820310014653 (Pubitemid 37184884)
101. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, Testa L, Stecco A, Tarletti R, Miglioretti M, Fava E, Nasuelli N, Cisari C, Massara M, Vercelli R, Oggioni GD, Carriero A, Cantello R, Monaco F, Fagioli F (2010) Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Experimental Neurol 223:229-237
102. D Karussis I Kassis BG Kurkalli S Slavin 2008 Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases J Neurol Sci 265 131 135 17610906 10.1016/j.jns.2007.05.005 1:CAS:528:DC%2BD1cXlsVWmuw%3D%3D
103. D Karussis C Karageorgiou A Vaknin-Dembinsky B Gowda-Kurkalli JM Gomori I Kassis JW Bulte P Petrou T Ben-Hur O Abramsky S Slavin 2010 Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis Arch Neurol 67 1187 1194 20937945 10.1001/archneurol.2010.248
104. Karussis D (2010) "multiple sclerosis AND stem cell". ClinicalTrialsgov A service of the US National Institutes of Health
105. MM Bonab S Yazdanbakhsh J Lofti 2010 Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study Iran J Immunol 4 50 57 (Pubitemid 46799666)
106. J Liang H Zhang B Hua H Wang J Wang Z Han L Sun 2009 Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis Mult Scler 15 644 646 19389752 10.1177/1352458509104590 1:STN:280: DC%2BD1M3pvVSqtg%3D%3D
107. R Saccardi T Kozak C Bocelli-Tyndall A Fassas A Kazis E Havrdova E Carreras A Saiz B Lowenberg PA te Boekhorst F Gualandio H Openshaw G Longo F Pagliai L Massacesi E Deconink J Ouyang FJ Nagore J Besalduch IA Lisukov A Bonini E Merelli S Slavino A Gratwohl J Passweg A Tyndall AJ Steck M Andolina M Capobianco JL Martin A Lugaresi G Meucci RA Saez RE Clark MN Fernandez L Fouillard B Herstenstein V Koza E Cocco H Baurmann GL Mancardi 2006 Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database Mult Scler 12 814 823 17263012 10.1177/1352458506071301 1:STN:280:DC%2BD2s%2FlvVyktg%3D%3D (Pubitemid 46111776)
108. ZX Zhang LX Guan K Zhang Q Zhang LJ Dai 2008 A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury Cytotherapy 10 134 139 18368592 10.1080/14653240701883061 1:CAS:528:DC%2BD1cXjslSrtbo%3D
109. NK Venkataramana SK Kumar S Balaraju RC Radhakrishnan A Bansal A Dixit DK Rao M Das M Jan PK Gupta SM Totey 2010 Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease Transl Res 155 62 70 20129486 10.1016/j.trsl.2009.07.006 1:CAS:528:DC%2BC3cXntVWjug%3D%3D
110. RW Mays W van't Hof AE Ting R Perry R Deans 2007 Development of adult pluripotent stem cell therapies for ischemic injury and disease Expert Opin Biol Ther 7 173 184 17250456 10.1517/14712598.7.2.173 1:CAS:528: DC%2BD2sXotVagsw%3D%3D (Pubitemid 46192166)
111. AE Ting RW Mays MR Frey WV Hof S Medicetty R Deans 2008 Therapeutic pathways of adult stem cell repair Crit rev oncol/hematol 65 81 93 10.1016/j.critrevonc.2007.09.007 (Pubitemid 350216478)